Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism.
about
Cellular and Molecular Mechanisms Underpinning Macrophage Activation during RemyelinationGenetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyUncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of human.Myeloperoxidase polymorphism, menopausal status, and breast cancer risk: an update meta-analysisAssociation of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus.Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897Association of myeloperoxidase with ovarian cancer.Recent progress in histochemistry and cell biology.Menopausal status modifies breast cancer risk associated with the myeloperoxidase (MPO) G463A polymorphism in Caucasian women: a meta-analysisHow dietary arachidonic- and docosahexaenoic- acid rich oils differentially affect the murine hepatic transcriptome.Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease.The human myeloperoxidase gene is regulated by LXR and PPARalpha ligands.Thiocyanate supplementation decreases atherosclerotic plaque in mice expressing human myeloperoxidase.Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor β/δ (PPARβ/δ)Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease.Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.Myeloperoxidase production by macrophage and risk of atherosclerosis.Carbamylation of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus.Relation of myeloperoxidase-463G/A polymorphism with metabolic syndrome and its component traits in Egyptian women.PPARγ disease gene network and identification of therapeutic targets for prostate cancer.2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis.Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflamed liver.In vivo imaging method to distinguish acute and chronic inflammation.Genetic polymorphisms of myeloperoxidase and their effect on hypertension.Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males.Liver X Receptor-Binding DNA Motif Associated With Atherosclerosis-Specific DNA Methylation Profiles of Alu Elements and Neighboring CpG Islands.Biosynthesis of human myeloperoxidase.Myeloperoxidase derived oxidants damage artery wall proteins in an animal model of chronic kidney disease accelerated atherosclerosis.A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients.Relation of myeloperoxidase promoter polymorphism and long-term hormone replacement therapy to oxidized low-density lipoprotein autoantibodies in postmenopausal women.Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study
P2860
Q26742081-396C22B6-F328-4434-97D7-328042257F93Q28536735-D7B5D1BB-02C3-4A60-9FA0-996171233DDFQ30494084-72AD9666-1AEF-411E-B423-8F67A4ED698DQ30951265-56C15EC2-7A33-493A-8DEC-189753D9F53EQ31133064-09E69CE3-18C6-472E-87C0-BC36B8B70F22Q33557464-0F10E419-DC56-43C3-A83A-6BA31F7EEBBBQ33561166-82DD302A-A3F9-45CD-8D5C-7565AB59E7F9Q33689246-E180D6CD-1B3A-4A3D-A53F-A365D10FBAEFQ34172616-6304E9F9-6347-4957-8D24-0AC54D1D0559Q34199792-AA5C1E8C-79DF-481A-9A41-D118A2C8B85AQ34681828-74F90061-EF5F-4489-A28C-E78298DA4291Q35070529-67807A12-4DFB-4069-8337-771627FB5045Q35697554-41FA88B9-B35D-45EC-BFB6-4BA97FE904EAQ35702958-E67661C1-89B4-4690-B4B3-E391090453D9Q36452006-ABCD5CF4-7AEC-40B3-944F-16FA7830E784Q37075304-C73C43FD-78CB-4F44-8B09-3E8F5C4CCC50Q37101754-6B2005AB-37CF-4AA9-9E6E-8B8112422232Q37291297-30C7B38E-1673-41C6-898A-2F9D606E1068Q37992526-DCBFCCAE-2F6F-41FA-BC09-A9FB97B9D32AQ38395463-3D8B2FC4-C48F-49E6-9C89-BDC33328A83FQ39240889-5FC907BD-045E-4C60-A0A1-87749C7EEC51Q39502492-820A1FFA-1B46-4C47-8318-B4B8A90F97C2Q40121384-DF249E60-7936-4C70-B371-19D600F3A298Q41206586-7AA38ABB-40C4-4E72-A8A8-BF07060DD9D2Q41879141-82C89AC7-7EB9-4028-8A9A-DF1D3FD7DDD8Q42836286-1368BCD9-BD08-49A4-B8A1-F5B78801075BQ44974222-6C3066EC-668A-462D-9646-6005E789DC64Q46071984-86B4A6E1-8E2E-448C-8B49-F2811AAE6651Q49546439-0D93DE8F-3D97-4DA0-8354-4B9F3F405B64Q50167687-CEE09798-C0F3-46A2-A120-5B4578E0FB80Q52629638-B3952A9B-12FA-4149-9B85-E31637E06C33Q52723580-15DDFDEA-C07D-4CC0-97A2-51FB4C9E47BFQ54587897-0F07AC4B-3ABF-467E-AECF-561CA114A26CQ57414500-89139B84-4F44-4C94-86CB-9BD5C8F29FA1
P2860
Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... -463GA promoter polymorphism.
@en
Peroxisome proliferator-activa ...... -463GA promoter polymorphism.
@nl
type
label
Peroxisome proliferator-activa ...... -463GA promoter polymorphism.
@en
Peroxisome proliferator-activa ...... -463GA promoter polymorphism.
@nl
prefLabel
Peroxisome proliferator-activa ...... -463GA promoter polymorphism.
@en
Peroxisome proliferator-activa ...... -463GA promoter polymorphism.
@nl
P2093
P2860
P356
P1476
Peroxisome proliferator-activa ...... -463GA promoter polymorphism.
@en
P2093
Alan P Kumar
F Javier Piedrafita
Wanda F Reynolds
P2860
P304
P356
10.1074/JBC.M311625200
P407
P577
2003-12-10T00:00:00Z